Merit CRO
MERIT: Specialized clinical trial endpoint services for ophthalmology, respiratory, and oncology sectors.
Founded
2012MERIT: Specialized clinical trial endpoint services for ophthalmology, respiratory, and oncology sectors.
Founded with a mission to enhance the accuracy and reliability of clinical trial endpoints, MERIT specializes in providing endpoint services for ophthalmology, respiratory, and oncology therapeutic areas. The company collaborates with contract research organizations (CROs), pharmaceutical, and biotech firms to support multi-regional clinical trials. MERIT's suite of services includes reading center services, clinical operations, and specialized software solutions like EXCELSIOR Imaging Software, aimed at ensuring precise data collection and analysis.
MERIT's leadership team comprises experts with extensive experience in clinical research and therapeutic specialties. The company has formed strategic partnerships with leading CROs and sponsors, bolstering its reputation in the industry. Notable achievements include successful collaborations on high-profile clinical trials and the development of innovative software tools that streamline trial processes. MERIT's impact is evident in its contribution to advancing medical research and improving patient outcomes across its specialized therapeutic areas.
Companies similar to Merit CRO include Endpoint Clinical, Accelerated Vision Group, Clinical Research IO and Clinical.ly.
Merit CRO was founded in 2012.
Merit CRO's headquarters is located in Madison, WI, US.
Merit CRO's most recent funding round was for $1.1M (USD) in July 2023.
As of Jul 20, 2023, Merit CRO has disclosed funding of $3.7M (USD). Undisclosed round amounts are excluded.
Merit CRO has 99 employees as of Feb 5, 2024.
clinical.ly
